Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking

Molecular and Cellular Biology

Volumn 17, Issue 3, 1997, Pages 1180-1188

  Giorgetti Peraldi, Sophie ^a   Ottinger, Elizabeth ^a   Wolf, Gert ^a   Ye, Bin ^b   Burke Jr , Terrence R ^b   Shoelson, Steven E ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; INSULIN; INSULIN RECEPTOR; PHORBOL ESTER; PHOSPHOTYROSINE; PROTEIN KINASE;

ANIMAL CELL; ARTICLE; DNA SYNTHESIS; IMMUNOBLOTTING; INTERNALIZATION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0031018904     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.3.1180     Document Type: Article

References (66)

1. Backer, J. M., S. E. Shoelson, E. Haring, and M. F. White. 1991. Insulin receptors internalize by a rapid, saturable pathway requiring receptor autophosphorylation and an intact juxtamembrane region. J. Cell Biol. 115:1535-1545.
2. Backer, J. M., S. E. Shoelson, M. A. Weiss, Q. X. Hua, B. Cheatham, E. Haring, D. C. Cahill, and M. F. White. 1992. The insulin receptor juxtamembrane region contains two independent tyrosine/β-turn internalization signals. J. Cell Biol. 118:831-839.
3. Blaikie, P., D. Immanuel, J. Wu, N. Li, V. Yajnik, and B. Margolis. 1994. A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. J. Biol. Chem. 269:32031-32034.
4. ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell 73:611-620.
5. Burke, T. R., M. S. Smyth, A. Otaka, M. Nozimu, P. P. Roller, G. Wolf, R. Case, and S. E. Shoelson. 1994. Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase resistant SH2 domain inhibitors. Biochemistry 33:6490-6494.
6. Burke, T. R., Jr., B. Ye, M. Akamatsu, H. Ford, X. Yan, H. K. Kole, G. Wolf, S. E. Shoelson, and P. P. Roller. 1996. 4′-O-[2-(2-Fluoromalonyl)-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides. J. Med. Chem. 39:1021-1027.
7. Campbell, K. S., E. Ogris, B. Burke, W. Su, K. R. Auger, B. J. Druker, B. S. Schaffhausen, T. M. Roberts, and D. C. Pallas. 1994. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Proc. Natl. Acad. Sci. USA 91:6344-6348.
8. Case, R. D., E. Piccione, G. Wolf, A. M. Bennett, R. J. Lechleider, B. G. Neel, and S. E. Shoelson. 1994. SH-PTP2/Syp SH2 domain specificity defined by direct interactions with PDGF β-receptor, EGF receptor and IRS-1 derived phosphopeptides. J. Biol. Chem. 269:10467-10474.
9. Chuang, L. M., M. G. Myers, J. M. Backer, S. E. Shoelson, M. F. White, M. J. Birnbaum, and C. R. Kahn. 1993. Insulin-stimulated oocyte maturation requires insulin receptor substrate 1 and interaction with the SH2 domains of phosphatidylinositol 3-kinase. Mol. Cell. Biol. 13:6653-6660.
10. Cutler, R. L., L. Liu, J. E. Damen, and G. Krystal. 1993. Multiple cytokines induce the tyrosine phosphorylation of Shc and its association with Grb2 in hemopoietic cells. J. Biol. Chem. 268:21463-21465.
11. Dikic, I., A. G. Batzer, P. Blaikie, A. Obermeier, A. Ulrich, J. Schlessinger, and B. Margolis. 1995. Shc binding to nerve growth factor receptor is mediated by phosphotyrosine interaction domain. J. Biol. Chem. 270:15125-15129.
12. Domchek, S. M., K. R. Auger, S. Chatterjee, T. R. Burke, and S. E. Shoelson. 1992. Inhibition of SH2 domain-phosphoprotein association by a nonhydrolyzable phosphonopeptide. Biochemistry 31:9865-9870.
13. Eck, M. J., S. Dhe-Paganon, T. Trub, R. Nolte, and S. E. Shoelson. 1996. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell 85:695-705.
14. Egan, S. E., B. W. Giddings, M. W. Brooks, L. Buday, A. M. Sizeland, and R. A. Weinberg. 1993. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363:45-51.
15. Ferguson, K. M., M. A. Lemmon, J. Schlessinger, and P. B. Sigler. 1995. Structure of the high affinity complex of inositol triphosphate with a PLC pleckstrin homology domain. Cell 83:1037-1046.
16. Gale, N. W., S. Kaplan, E. J. Lowenstein, J. Schlessinger, and D. Bar-Sagi. 1993. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature 363:88-92.
17. Giorgetti, S., P. G. Pelicci, G. Pelicci, and E. Van Obberghen. 1994. Involvement of Shc proteins in signaling through the insulin and IGF-1 receptors. Eur. J. Biochem. 223:195-202.
18. Goncalves, E., K. Yamada, H. S. Thatte, J. M. Backer, D. E. Golan, C. R. Kahn, and S. E. Shoelson. 1993. Optimizing transmembrane domain helicity accelerates insulin receptor internalization and lateral mobility. Proc. Natl. Acad. Sci. USA 90:5762-5766.
19. Gustafson, T. A., W. He, A. Craparo, C. D. Schaub, and T. J. O'Neill. 1995. Phosphotyrosine-dependent interaction of Shc and IRS-1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol. Cell. Biol. 15:2500-2508.
20. He, W., T. J. O'Neill, and T. A. Gustafson. 1995. Distinct modes of interaction of SHC and insulin receptor substrate-1 with the insulin receptor NPEY region via non-SH2 domains. J. Biol. Chem. 270:23258-23262.
21. Hyvonen, M., M. J. Macias, M. Nilges, H. Oschkinat, M. Saraste, and M. Wilmanns. 1995. Structure of the binding site for inositol phosphates in a PH domain. EMBO J. 14:4676-4685.
22. Isakoff, S. J., Y. P. Yu, Y. C. Su, P. Blaikie, V. Yajnik, E. Rose, K. M. Weidner, M. Sachs, B. Margolis, and E. Y. Skolnik. 1996. Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo. J. Biol. Chem. 271: 3959-3962.
23. Johnston, J. A., L.-M. Wang, E. P. Hanson, X.-J. Sun, M. F. White, S. A. Oakes, J. H. Pierce, and J. J. O'Shea. 1995. Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. J. Biol. Chem. 270:28527-28530.
24. Kavanaugh, W. M., C. W. Turck, and L. T. Williams. 1995. PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. Science 268:1177-1179.
25. Kavanaugh, W. M., and L. T. Williams. 1994. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science 266:1862-1865.
26. Kuhne, M. R., T. Pawson, G. E. Lienhard, and G. S. Feng. 1993. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J. Biol. Chem. 268:11479-11481.
27. Laminet, A. A., G. Apell, L. Conroy, and W. M. Kavanaugh. 1996. Affinity, specificity, and kinetics of the interaction of the SHC phosphotyrosine binding domain with asparagine-X-X-phosphotyrosine motifs of growth factor receptors. J. Biol. Chem. 271:264-269.
28. Lee, J., T. O'Hare, P. F. Pilch, and S. E. Shoelson. 1993. Insulin receptor autophosphorylation occurs asymmetrically. J. Biol. Chem. 268:4092-4098.
29. Lee, J., S. E. Shoelson, and P. F. Pilch. 1995. Intermolecular phosphorylation between insulin holoreceptors does not stimulate substrate kinase activity. J. Biol. Chem. 270:31136-31140.
30. Milarski, K. L., and A. R. Saltiel. 1994. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J. Biol. Chem. 269:21239-21243.
31. Noguchi, T., T. Matozaki, K. Horita, Y. Fujioka, and M. Kasuga. 1994. Role of SH-PTP2, a protein tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated ras activation. Mol. Cell. Biol. 14:6674-6082.
32. Okabayashi, Y., Y. Sugimoto, N. F. Totty, J. Hsuan, Y. Kido, K. Sakaguchi, I. Gout, M. D. Waterfield, and M. Kasuga. 1996. Interaction of Shc with adapter protein adaptins. J. Biol. Chem. 271:5265-5269.
33. O'Neill, T. J., A. Craparo, and T. A. Gustafson. 1994. Characterization of an interaction between insulin receptor substrate 1 and the insulin receptor by using the two-hybrid system. Mol. Cell. Biol. 14:6433-6442.
34. Payne, D. M., A. J. Rossomondo, P. Martino, A. K. Erickson, J. H. Her, J. Shabanowitz, D. F. Hunt, M. J. Weber, and T. W. Sturgill. 1991. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J. 10:885-892.
35. Pelicci, G., L. Lanfrancone, F. Grignani, J. McGlade, F. Cavallo, G. Forni, I. Nicoletti, T. Pawson, and P. G. Pelicci. 1992. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93-104.
36. Piccione, E., R. D. Case, S. M. Domchek, P. Hu, M. Chaudhuri, J. M. Backer, J. Schlessinger, and S. E. Shoelson. 1993. PI 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding. Biochemistry 32:3197-3202.
37. Prigent, S. A., T. S. Pillay, K. S. Ravichandran, and W. J. Gullick. 1995. Binding of Shc to the NPXY motif is mediated by its N-terminal domain. J. Biol. Chem. 270:22097-22100.
38. Pronk, G. J., J. McGlade, G. Pelicci, T. Pawson, and J. L. Bos. 1993. Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. J. Biol. Chem. 268:5748-5753.
39. Rajagopalan, M., J. L. Neidigh, and D. A. McClain. 1991. Amino acid sequences Gly-Pro-Leu-Tyr and Asn-Pro-Glu-Tyr in the submembranous domain of the insulin receptor are required for normal endocytosis. J. Biol. Chem. 266:23068-23073.
40. Raptis, L. H., S. K.-W. Liu, K. L. Firth, C. D. Stiles, and J. A. Alberta. 1995. Electroporation of peptides into adherent cells in situ. BioTechniques 18: 104-114.
41. Ravichandran, K. S., K. K. Lee, Z. Songyang, L. C. Cantley, P. Burn, and S. J. Burakoff. 1993. Interaction of Shc with the zeta chain of the T cell receptor upon T cell activation. Science 262:902-905.
42. Ricketts, W. A., D. W. Rose, S. E. Shoelson, and J. M. Olefsky. 1996. Functional roles of the Shc PTB and SH2 domains in insulin and EGF signaling. J. Biol. Chem. 271:26165-26169.
43. Rozakis-Adcock, M., R. Fernley, J. Wade, T. Pawson, and D. Bowtell. 1993. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 363:83-85.
44. Rozakis-Adcock, M., J. McGlade, G. Mbamalu, G. Pelicci, R. Daly, W. Li, A. Batzer, S. Thomas, J. Brugge, P. G. Pelicci, J. Schlessinger, and T. Pawson. 1992. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360:689-692.
45. Ruff-Jamison, S., J. McGlade, T. Pawson, K. Chen, and S. Cohen. 1993. Epidermal growth factor stimulates the tyrosine phosphorylation of SHC in the mouse. J. Biol. Chem. 268:7610-7612.
46. ras-GTP formation. J. Biol. Chem. 269:10734-10738.
47. Segatto, O., G. Pelicci, S. Giuli, G. Digiesi, P. Di Fiore, J. McGlade, T. Pawson, and P. G. Pelicci. 1993. Shc products are substrates of erbB-2 kinase. Oncogene 8:2105-2112.
48. Shoelson, S. E., S. Chatterjee, M. Chaudhuri, and T. R. Burke. 1991. Solid-phase synthesis of nonhydrolyzable phosphotyrosyl peptide analogues with Nα-Fmoc-(O,O-di-t-butyl) phosphono-p-methylphenylalanine. Tetrahedron Lett. 32:6061-6064.
49. Skolnik, E. Y., C. H. Lee, A. G. Batzer, L. M. Vicentini, M. Zhou, R. J. Daly, M. G. Myers, Jr., J. M. Backer, A. Ullrich, M. F. White, and J. Schlessinger. 1993. The SH2/SH3 domain containing protein GRB2 interacts with tyrosine phosphorylated IRS1 and Shc: implications for insulin control of ras signaling. EMBO J. 12:1929-1936.
50. Smyth, M. S., and T. R. Burke. 1994. Enantioselective synthesis of N-Boc and N-Fmoc protected diethyl 4-phosphonodifluoromethyl-L-phenylalanine; agents suitable for the solid-phase synthesis of peptides containing nonhydrolyzable analogues of O-phosphotyrosine. Tetrahedron Lett. 35:551-555.
51. Songyang, Z., B. Margolis, M. Chaudhuri, S. E. Shoelson, and L. C. Cantley. 1995. The phosphotyrosine interaction domain of Shc recognizes tyrosine-phosphorylated NPXY motif. J. Biol. Chem. 270:14863-14866.
52. Souza, S. C., G. P. Frick, R. Yip, R. B. Lobo, L.-R. Tai, and H. M. Goodman. 1994. Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 269:30085-30088.
53. Sun, X. J., D. L. Crimmins, M. G. Myers, Jr., M. Miralpeix, and M. F. White. 1993. Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol. Cell. Biol. 13:7418-7428.
54. Sun, X. J., P. Rothenberg, C. R. Kahn, J. M. Backer, E. Araki, P. A. Wilden, D. A. Cahill, B. J. Goldstein, and M. F. White. 1991. The structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77.
55. Thies, R. S., N. J. Webster, and D. A. McClain. 1990. A domain of the insulin receptor required for endocytosis in rat fibroblasts. J. Biol. Chem. 265: 10132-10137.
56. Trub, T., W. E. Choi, G. Wolf, E. Ottinger, Y. Chen, M. A. Weiss, and S. E. Shoelson. 1995. Specificity of the PTB domain of Shc for β turn-forming pentapeptide motifs amino-terminal to phosphotyrosine. J. Biol. Chem. 270: 18205-18208.
57. van der Geer, P., S. Wiley, V. K.-M. Lai, J. P. Olivier, G. D. Gish, R. Stephens, D. Kaplan, S. E. Shoelson, and T. Pawson. 1995. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated growth factor receptors and phosphopeptides. Curr. Biol. 5:404-412.
58. Wang, L. M., M. G. Myers, X. J. Sun, S. A. Aaronson, M. F. White, and J. H. Pierce. 1993. IRS-1: essential for insulin and IL-4-stimulated mitogenesis in hematopoietic cells. Science 261:1591-1594.
59. Wolf, G., T. Trub, E. Ottinger, L. Groninga, A. Lynch, M. White, M. Miyazaki, J. Lee, and S. E. Shoelson. 1995. The PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities. J. Biol. Chem. 270: 27407-27410.
60. Xiao, S., D. W. Rose, T. Sasoka, H. Maegawa, T. R. Burke, P. P. Roller, S. E. Shoelson, and J. M. Olefsky. 1994. Syp/SH-PTP2 is a positive mediator of growth factor stimulated mitogenic signal transduction. J. Biol. Chem. 269: 21244-21248.
61. Yamada, K., J. L. Carpentier, B. Cheatham, E. Goncalves, S. E. Shoelson, and C. R. Kahn. 1995. Role of the transmembrane domain and flanking amino acids in internalization and down-regulation of insulin receptor. J. Biol. Chem. 270:3115-3122.
62. Yamauchi, K., K. L. Milarski, A. R. Saltiel, and J. E. Pessin. 1995. Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. Proc. Natl. Acad. Sci. USA 92:664-668.
63. Yamauchi, K., V. Ribon, A. R. Saltiel, and J. E. Pessin. 1995. Identification of the major SHPTP2-hinding protein that is tyrosine-phosphorylated in response to insulin. J. Biol. Chem. 270:17716-17722.
64. Ye, B., M. Akamatsu, S. E. Shoelson, G. Wolf, S. Giorgetti-Peraldi, X. Yan, P. Roller, and T. R. Burke. 1995. L-O-(2-Malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides. J. Med. Chem. 38:4270-4275.
65. Zhou, M.-M., B. Huang, E. T. Olejniczak, R. P. Meadows, S. B. Shuker, M. Miyazaki, T. Trub, S. E. Shoelson, and S. W. Fesik. 1996. Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. Nat. Struct. Biol. 3:388-393.
66. Zhou, M.-M., K. S. Ravichandran, E. T. Olejniczak, A. M. Petros, R. P. Meadows, J. E. Harlan, W. S. Wade, S. J. Burakoff, and S. W. Fesik. 1995. Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Nature 378:584-592.